Miller et al., 1977 [58] |
160 |
Single-centre retrospective case series |
Low |
No ICP threshold for outcome in patients with mass lesion. When ICP was 0–10 mmHg in patients without mass lesions, 85 % made a good recovery (GOS 4–5) and 8 % died. When ICP was 11– 20 mmHg, good recovery rate was 64 and 25 % died (χ2 = 5.30; p < 0.02) |
All patients treated for elevated ICP. Minimal risk adjustment or multifactorial analysis |
Nordby and Gunnerod, 1985 [47] |
130 |
Single-centre retrospective case series |
Low |
Significantly worse outcome in patients whose ICP exceeded 20 mmHg (p < 0.001). ICP ≥ 40 mmHg had high risk of progressing to brain death |
All patients treated for elevated ICP. Minimal risk adjustment or multifactorial analysis. Epidural monitoring |
Marshall et al. 1979 [72] |
100 |
Single-centre retrospective case series |
Low |
For patients without mass lesions with ICP < 15 mmHg, 77 % achieved favorable outcome (GOS = 4–5) versus those with ICP ≥ 15 mmHg for ≥15 min, wherein 42 % achieved favourable outcome (p < 0.01 by univariate analysis). Favorable outcomes were achieved in 43 % with ICP ≥ 15 for 15 min and in 42 % with ICP > 40 mmHg for 15 min |
All patients treated for ICP > 15 mmHg. Minimal risk adjustment or multifactorial analysis |
Saul and Ducker, 1982 [37] |
233 |
Single-centre, retrospective, sequential case series’ comparing two protocols |
Low |
Mortality rate was 46 % for those treated with a 20–25 mmHg threshold protocol versus 28 % for those treated with a 15 mmHg protocol (p < 0.0005 by univariate analysis). For those with ICP’s ≥ 25 mmHg, respective mortality was 84 versus 69 % (p < 0.05). For those with ICP’s ≤ 25 mmHg, respective mortalities were 26 % and 15 % (p < 0.025) |
Threshold analysis confounded by concomitant general protocol effects. Minimal risk adjustment or multifactorial analysis |
Marmarou et al. 2005 [85] |
428 |
Multi-centre retrospective analysis of prospectively collected database |
Low |
The proportion of measurements with ICP > 20 mmHg was the most powerful predictor of 6 month outcome after age, admission GCS motor score, and abnormal admission pupils. The full model correctly explained 53 % of observed outcomes. ICP proportion modeling power peaked at 20 mmHg |
Confounding by choice of threshold, variable responses to supra-threshold values of different magnitudes, the beneficial and toxic effects of treatments, and the interaction of ICP with other variables in individual patients. Their model assumes equal effect of each descriptor over its entire range |
Chambers et al. 2001 [87] |
207 adults |
Single-centre retrospective observational study |
Low |
ROC analysis of maximum ICP from hourly averages of automated ICP data found optimal prediction of 6 month dichotomized GOS outcome to be 35 mmHg |
Studied only maximal ICP values |
Ratanalert et al. 2004 [86] |
27 |
Prospective randomized trial of protocolised treatment at two different ICP thresholds (20 vs. 25 mmHg) |
Low |
No significant difference in 6-month GOS by univariate or multivariate analysis |
Very small sample size. Little detail provided on study design and management |
Smith et al. 1986 [80] |
77 |
Prospective randomized trial of patients treated based on ICP versus scheduled treatment |
Low |
No significant difference in 1 year GOS by univariate analysis. Mean ICP 5.5 mmHg higher in monitorbased-treatment group |
Small sample size. Investigation not designed to study ICP threshold |
Resnick et al. 1997 [88] |
37 |
Single-centre retrospective observational study on patients with ICP > 20 mmHg that persisted for >96 h |
Low |
38 % reached GOS 4–5 at ≥6 months; 43 % GOS 1–2. Patients < 30 years had better outcome, 57 % reaching GOS 4–5 versus 12.5 % (p < 0.02). Patients with good outcomes were significantly younger (p = 0.0098). The association of age and GCS with outcome was significant (p < 0.005) |
No detail on the degree of ICP resistance or magnitude of related insults (low CPP, herniation) |
Young et al. 2003 [89] |
9 |
Single-centre retrospective observational study of patients with ICP > 25 for ≥2 h |
Low |
Mortality = 56 %. 44 % survived, with GOS = 4 at rehabilitation discharge |
Small series. No quantification of ICP or CPP insults. No comparison to those who died |
Vik et al. 2008 [53] |
93 |
Single-centre retrospective observational trial analyzing ICP as AUC |
Low |
The dose of ICP was an independent predictor of death (OR 1.04; 95 % CI 1.003–1.08; p = 0.035) and poor outcome (OR 1.05; 95 % CI 1.003–1.09; p = 0.034) at 6 months, by multiple regression |
No control for monitoring duration or terminal events. Arbitrary stratification of AUC categories |
Kahraman et al. 2010 [90] |
30 |
Single-centre retrospective observational trial using prospective data analyzing manual versus automated ICP as AUC versus mean |
Low |
For automated data, total ICU AUC had high predictive power for GOS-E 1–4 (area under the ROC curve = 0.92 ± 0.05) and moderate predictive power for in-hospital mortality (0.76 ± 0.15). The percentage of monitoring time that ICP > 20 mmHg had significantly lower predictive power for 3 month GOS-E compared with AUC using 20 mmHg as the cutoff (p = 0.016) |
|